Chemoinformaics analysis of 1-(2,6,6-trimethylcyclohexen-1-yl)prop-2-en-1-one
| Molecular Weight | 218.34 | nRot | 3 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 11 |
| Exact Molecular Weight | 218.167 | nRing | 2 |
| Solubility: LogS | -5.191 | nHRing | 0 |
| Solubility: LogP | 4.648 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.653 |
| Synth | 2.974 |
| Natural Product Likeliness | 1.513 |
| NR-PPAR-gamma | 0.031 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.865 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.631 |
| MDCK | 0.0000208 |
| BBB | 0.088 |
| PPB | 0.970424 |
| VDSS | 2.675 |
| FU | 0.0224647 |
| CYP1A2-inh | 0.864 |
| CYP1A2-sub | 0.942 |
| CYP2c19-inh | 0.881 |
| CYP2c19-sub | 0.881 |
| CYP2c9-inh | 0.776 |
| CYP2c9-sub | 0.761 |
| CYP2d6-inh | 0.937 |
| CYP2d6-sub | 0.554 |
| CYP3a4-inh | 0.693 |
| CYP3a4-sub | 0.338 |
| CL | 1.929 |
| T12 | 0.233 |
| hERG | 0.037 |
| Ames | 0.06 |
| ROA | 0.103 |
| SkinSen | 0.916 |
| Carcinogencity | 0.702 |
| EI | 0.956 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.206 |
| Antiviral | Yes |
| Prediction | 0.918465 |